Herrmann E - Search Results

1

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ. Nuhn P, et al. Among authors: herrmann e. Eur J Surg Oncol. 2012 Jul;38(7):637-42. doi: 10.1016/j.ejso.2012.02.187. Epub 2012 Mar 27. Eur J Surg Oncol. 2012. PMID: 22459902

2

Histologic subtype of metastatic renal cell carcinoma predicts response to combined immunochemotherapy with interleukin 2, interferon alpha and 5-fluorouracil.

Herrmann E, Brinkmann OA, Bode ME, Bierer S, Köpke T, Bögemann M, Hertle L, Wülfing C. Herrmann E, et al. Eur Urol. 2007 Jun;51(6):1625-31; discussion 1631-2. doi: 10.1016/j.eururo.2006.11.003. Epub 2006 Nov 13. Eur Urol. 2007. PMID: 17113215

3

Expression of the Endothelin-axis in the different histologic subtypes of renal cell carcinoma: a tissue microarray analysis.

Herrmann E, Eltze E, Bierer S, Bogemann M, Brinkmann OA, Balnowair H, Hertle L, Wulfing C. Herrmann E, et al. Oncol Rep. 2007 Feb;17(2):275-80. Oncol Rep. 2007. PMID: 17203161

4

The role of the endothelin axis and microvessel density in bladder cancer - correlation with tumor angiogenesis and clinical prognosis.

Herrmann E, Bögemann M, Bierer S, Eltze E, Toma MI, Köpke T, Hertle L, Wülfing C. Herrmann E, et al. Oncol Rep. 2007 Jul;18(1):133-8. Oncol Rep. 2007. PMID: 17549358

5

[Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].

Herrmann E, Wülfing C, Hartmann A. Herrmann E, et al. Urologe A. 2007 Sep;46(9):1175-6. doi: 10.1007/s00120-007-1450-2. Urologe A. 2007. PMID: 17646959 German. No abstract available.

6

[Lymphangiogenesis axis in bladder carcinoma. An analysis with tissue microarray technology].

Herrmann E, Eltze E, Bierer S, Hertle L, Wülfing C. Herrmann E, et al. Urologe A. 2007 Sep;46(9):1254-6. doi: 10.1007/s00120-007-1492-5. Urologe A. 2007. PMID: 17676294 German. No abstract available.

7

[New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C. Herrmann E, et al. Aktuelle Urol. 2007 Sep;38(5):392-7. doi: 10.1055/s-2007-980110. Aktuelle Urol. 2007. PMID: 17907066 German.

8

VEGF-C, VEGF-D and Flt-4 in transitional bladder cancer: relationships to clinicopathological parameters and long-term survival.

Herrmann E, Eltze E, Bierer S, Köpke T, Görge T, Neumann J, Hertle L, Wülfing C. Herrmann E, et al. Anticancer Res. 2007 Sep-Oct;27(5A):3127-33. Anticancer Res. 2007. PMID: 17970053 Free article.

9

The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.

Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C. Herrmann E, et al. Int J Urol. 2008 Jul;15(7):607-11. doi: 10.1111/j.1442-2042.2008.02059.x. Epub 2008 May 2. Int J Urol. 2008. PMID: 18462352

10

Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.

Bolenz C, Fernández MI, Trojan L, Herrmann E, Becker A, Weiss C, Alken P, Ströbel P, Michel MS. Bolenz C, et al. Among authors: herrmann e. Urology. 2008 Aug;72(2):364-9. doi: 10.1016/j.urology.2008.04.032. Epub 2008 Jun 24. Urology. 2008. PMID: 18579189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

885 results

Search Page

Filters